December 23rd 2024
The FDA has approved the first generic once-daily GLP-1 injection for the improvement of glycemic control for type 2 diabetes in patients 10 years and up.
Cytokine Blocker Eases Beta Cell Stress in Type 2 Diabetes
April 11th 2007ZURICH, Switzerland -- Blockade of the inflammatory cytokine interleukin-1 with a receptor antagonist improved blood glucose control and insulin secretion and reduced inflammation markers in patients with type 2 diabetes, Swiss researchers reported
How Safe Is Alcohol for Patients With Diabetes?
March 1st 2007Alcohol ingestion is one of the most common causes of disabling hypoglycemiain the United States. The effects of alcohol ingestion onpatients with diabetes vary considerably, depending on whether they havetype 1 or type 2 diabetes and on whether they are receiving insulin therapy.
Diabetic Foot Problems: Keys to Effective, Aggressive Prevention
March 1st 2007ABSTRACT: A 4-pronged approach that includes patient education, skin and nail care, appropriate footwear, and proactive surgeries can effectively prevent diabetic foot problems. Teach patients with diabetes to examine their feet daily to detect new onset of redness, swelling, breaks in the integrity of the skin, blisters, calluses, and macerated areas. Have them follow a daily foot care regimen that includes warm water soaks and lubrication, and have them keep toenails properly trimmed. Recommend that patients select shoes that fit properly and have sufficient padding and toe box space; have them use inserts, lifts, orthoses, or braces--as recommended-to correct abnormal gait patterns. Finally, if deformities develop, simple proactive surgical procedures can correct these problems before they result in the development of wounds.
DAVIDSON’S DIABETES MELLITUS:DIAGNOSIS AND TREATMENT (ed 5)
January 1st 2007Despite impressive advances in the treatment of diabetesmellitus over the past quarter century, the disease continuesto have devastating consequences. It is the leading cause ofblindness in adults younger than 75 years, the cause of morethan 50% of lower leg amputations, and the cause of deathin 75% of affected patients. Moreover, the incidence of diabetesis rising rapidly. This 5th edition of a classic referenceprovides step-by-step guidance on the office management ofthe disease, from the initial evaluation through approachesto such specific issues as travel, hygiene, and weight control.The discussion of treatment options has been updated andincludes newer insulin analogs, recently approved medications,and combination therapy. New chapters cover medicalnutrition therapy, insulin resistance and macrovascular disease,and diabetes in children. Up-to-date discussions of thepsychological implications of the disease and findings fromthe United Kingdom Prospective Diabetes Study are also included.The book is illustrated with numerous tables, algorithms,graphs, and diagrams. In addition, patient educationworksheets and handouts are provided.
Aspirin Therapy to Prevent CVD in Patients With Diabetes: Recommendations From the ADA
December 31st 2006Men and women with diabetes are 2 to 4 times more likelythan other persons to die of complications of cardiovasculardisease (CVD). Solid evidence from primary andsecondary prevention trials has prompted the AmericanDiabetes Association to recommend low-dose aspirin therapyfor patients with diabetes who either have or are athigh risk for CVD (Table).
Gestational Diabetes: Worth Testing For? Worth Treating?
December 31st 2006Is there evidence that treating elevated fasting glucose levels or impairedglucose tolerance, from early in pregnancy until term, improves outcomes(ie, fewer cesarean deliveries, fewer macrosomic babies, fewer patients in whompreeclampsia develops, fewer mothers who subsequently require insulin)?